COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY
COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY